This Mutation Likely Saved a Colon Cancer Patient's Life
His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Gastroschisis Repair | Genetics | Health | Immunotherapy | Rectal Cancers